If the Bourgogne-Franche-Comté region is the cradle of microtechnology, it is the combination of these technologies with cell therapies that has enabled the RIGHT Institute to produce flagship products such as CAR-T cells!
These innovations were highlighted on 14 and 15 October 2021, as Besançon welcomed the world’s leading players specialising in the development of innovative therapies, their production and their regulatory framework.
Clinicians, scientists and industrial partners presented their latest scientific advances on the development of CAR-T cells, stem cells or pluripotent cells, their transfer to clinical trials and the challenges of their industrial production.
This wide range of players, from the academic to the private sector, from the local to the international level, gave their vision of the use of innovative therapies in the medicine of tomorrow. The « Innovative Therapies Days » will focus on exchanges between partners through an Exhibitors’ Village, B2B sessions and discussion sessions.
The Innovative Therapies Days will make the connection between the academic and the industrial worlds: from research, to clinical trials, to industrialisation. CAR-T CELLS (I) – (II) Chimeric Antigen Receptor T cells therapy (CAR-T) has revolutionized the course of disease...Learn more